Kainova Therapeutics has dosed the first patient in Europe in its DOMISOL phase 1/2 trial of DT 7012, expanding...
Lire la suiteBiogen has secured US FDA approval for a high dose Spinraza regimen for spinal muscular atrophy. Viridian Therapeutics has...
Lire la suiteDNA Script is expanding access to its SYNTAX platform across Latin America, South Korea and Japan through new distribution...
Lire la suiteArvinas has reported encouraging phase 1 data for ARV-102, an investigational PROTAC degrader for Parkinson’s disease. R1 Therapeutics has...
Lire la suiteMHRA has approved deuruxolitinib, marketed as Leqselvi, for adults with severe alopecia areata, adding a new prescription treatment option...
Lire la suiteKatalyze Data and SAS have developed DementAI, a UK-built artificial intelligence system designed to help identify Alzheimer’s disease risk...
Lire la suite